Published • loading... • Updated
Cell X Technologies and BioLamina enter a collaboration to advance standardization in iPSC-based therapeutics
Summary by Eastern Progress
1 Articles
1 Articles
Cell X Technologies and BioLamina enter a collaboration to advance standardization in iPSC-based therapeutics
WOBURN, Mass., Sept. 29, 2025 /PRNewswire/ -- Cell X Technologies today announced a collaboration with BioLamina to integrate BioLamina's defined laminin reagents (Biolaminin®) with Cell X's Celligent™ platform, aiming to reduce variability and enhance reproducibility in advanced therapy manufacturing.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium